Sage Therapeutics, Inc. to Post Q3 2024 Earnings of ($1.51) Per Share, Leerink Partnrs Forecasts (NASDAQ:SAGE)
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 earnings estimates for shares of Sage Therapeutics in a research report issued on Wednesday, July 31st. Leerink Partnrs analyst M. Goodman now anticipates that the biopharmaceutical company will post earnings of ($1.51) per share for the quarter, up […]
More Stories
Gray Television (NYSE:GTN.A) Shares Gap Down – Here’s Why
Gray Television, Inc. (NYSE:GTN.A – Get Free Report) shares gapped down before the market opened on Monday . The stock...
Newmont (NYSE:NEM) Shares Gap Down on Analyst Downgrade
Newmont Co. (NYSE:NEM – Get Free Report) shares gapped down before the market opened on Monday after Raymond James lowered...
Modular Medical Completes Underwritten Public Offering to Raise $8.2 MillionSan Diego, CA – Modular Medical, Inc. (NASDAQ: MODD) successfully closed an underwritten public offering on November 25, 2024, resulting in gross proceeds of approximately $8
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
Hut 8 (NASDAQ:HUT) Stock Price Down 7% – Here’s Why
Shares of Hut 8 Corp. (NASDAQ:HUT – Get Free Report) fell 7% during mid-day trading on Monday . The stock...
Astera Labs (NASDAQ:ALAB) Trading Up 7.8% – Time to Buy?
Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s share price traded up 7.8% during mid-day trading on Monday . The...
Joby Aviation (NYSE:JOBY) Sees Strong Trading Volume – Still a Buy?
Joby Aviation, Inc. (NYSE:JOBY – Get Free Report) saw unusually-high trading volume on Monday . Approximately 3,385,534 shares were traded...